Selected research
Industry Research
Mycoplasma Detection System Industry Research Report 2026
Market perspective
The global Mycoplasma Detection System market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Mycoplasma Detection System is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Mycoplasma Detection System is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Mycoplasma Detection System is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Mycoplasma Detection System include Thermo Fisher Scientific, Transgen Biotech Co, Sartorius, R and D Systems, Merck, Lonza, InvivoGen, Eurofins and Charles River Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Mycoplasma Detection System market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Mycoplasma Detection System Market by Company
Thermo Fisher Scientific
Transgen Biotech Co
Sartorius
R and D Systems
Merck
Lonza
InvivoGen
Eurofins
Charles River Laboratories
BioMérieux
Applied Biological Materials Inc
Agilent Technologies
Mycoplasma Detection System Segment by Type
PCR Based Systems
Luminescence Based Systems
Others
Mycoplasma Detection System Segment by Application
Pharmaceutical Companies
Academic Research Institutes
Others
Mycoplasma Detection System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mycoplasma Detection System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mycoplasma Detection System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mycoplasma Detection System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Mycoplasma Detection System manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Mycoplasma Detection System by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Mycoplasma Detection System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- PCR Based Systems
- Luminescence Based Systems
- Others
Applications
- Pharmaceutical Companies
- Academic Research Institutes
- Others
Companies covered
- Thermo Fisher Scientific
- Transgen Biotech Co
- Sartorius
- R and D Systems
- Merck
- Lonza
- InvivoGen
- Eurofins
- Charles River Laboratories
- BioMérieux
- Applied Biological Materials Inc
- Agilent Technologies
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Mycoplasma Detection System Market Size (2021-2032)
- 2.2.2 Global Mycoplasma Detection System Sales (2021-2032)
- 2.2.3 Global Mycoplasma Detection System Market Average Price (2021-2032)
- 2.3 Mycoplasma Detection System by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 PCR Based Systems
- 2.3.3 Luminescence Based Systems
- 2.3.4 Others
- 2.4 Mycoplasma Detection System by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical Companies
- 2.4.3 Academic Research Institutes
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Mycoplasma Detection System Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Mycoplasma Detection System Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Mycoplasma Detection System Revenue of Manufacturers (2021-2026)
- 3.4 Global Mycoplasma Detection System Average Price by Manufacturers (2021-2026)
- 3.5 Global Mycoplasma Detection System Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Mycoplasma Detection System, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Mycoplasma Detection System, Product Type & Application
- 3.8 Global Manufacturers of Mycoplasma Detection System, Established Date
- 3.9 Global Mycoplasma Detection System Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher Scientific
- 4.1.1 Thermo Fisher Scientific Company Information
- 4.1.2 Thermo Fisher Scientific Business Overview
- 4.1.3 Thermo Fisher Scientific Mycoplasma Detection System Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Scientific Mycoplasma Detection System Product Portfolio
- 4.1.5 Thermo Fisher Scientific Recent Developments
- 4.2 Transgen Biotech Co
- 4.2.1 Transgen Biotech Co Company Information
- 4.2.2 Transgen Biotech Co Business Overview
- 4.2.3 Transgen Biotech Co Mycoplasma Detection System Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Transgen Biotech Co Mycoplasma Detection System Product Portfolio
- 4.2.5 Transgen Biotech Co Recent Developments
- 4.3 Sartorius
- 4.3.1 Sartorius Company Information
- 4.3.2 Sartorius Business Overview
- 4.3.3 Sartorius Mycoplasma Detection System Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sartorius Mycoplasma Detection System Product Portfolio
- 4.3.5 Sartorius Recent Developments
- 4.4 R and D Systems
- 4.4.1 R and D Systems Company Information
- 4.4.2 R and D Systems Business Overview
- 4.4.3 R and D Systems Mycoplasma Detection System Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 R and D Systems Mycoplasma Detection System Product Portfolio
- 4.4.5 R and D Systems Recent Developments
- 4.5 Merck
- 4.5.1 Merck Company Information
- 4.5.2 Merck Business Overview
- 4.5.3 Merck Mycoplasma Detection System Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Merck Mycoplasma Detection System Product Portfolio
- 4.5.5 Merck Recent Developments
- 4.6 Lonza
- 4.6.1 Lonza Company Information
- 4.6.2 Lonza Business Overview
- 4.6.3 Lonza Mycoplasma Detection System Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Lonza Mycoplasma Detection System Product Portfolio
- 4.6.5 Lonza Recent Developments
- 4.7 InvivoGen
- 4.7.1 InvivoGen Company Information
- 4.7.2 InvivoGen Business Overview
- 4.7.3 InvivoGen Mycoplasma Detection System Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 InvivoGen Mycoplasma Detection System Product Portfolio
- 4.7.5 InvivoGen Recent Developments
- 4.8 Eurofins
- 4.8.1 Eurofins Company Information
- 4.8.2 Eurofins Business Overview
- 4.8.3 Eurofins Mycoplasma Detection System Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Eurofins Mycoplasma Detection System Product Portfolio
- 4.8.5 Eurofins Recent Developments
- 4.9 Charles River Laboratories
- 4.9.1 Charles River Laboratories Company Information
- 4.9.2 Charles River Laboratories Business Overview
- 4.9.3 Charles River Laboratories Mycoplasma Detection System Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Charles River Laboratories Mycoplasma Detection System Product Portfolio
- 4.9.5 Charles River Laboratories Recent Developments
- 4.10 BioMérieux
- 4.10.1 BioMérieux Company Information
- 4.10.2 BioMérieux Business Overview
- 4.10.3 BioMérieux Mycoplasma Detection System Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 BioMérieux Mycoplasma Detection System Product Portfolio
- 4.10.5 BioMérieux Recent Developments
- 4.11 Applied Biological Materials Inc
- 4.11.1 Applied Biological Materials Inc Company Information
- 4.11.2 Applied Biological Materials Inc Business Overview
- 4.11.3 Applied Biological Materials Inc Mycoplasma Detection System Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Applied Biological Materials Inc Mycoplasma Detection System Product Portfolio
- 4.11.5 Applied Biological Materials Inc Recent Developments
- 4.12 Agilent Technologies
- 4.12.1 Agilent Technologies Company Information
- 4.12.2 Agilent Technologies Business Overview
- 4.12.3 Agilent Technologies Mycoplasma Detection System Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Agilent Technologies Mycoplasma Detection System Product Portfolio
- 4.12.5 Agilent Technologies Recent Developments
5 Global Mycoplasma Detection System Market Scenario by Region
- 5.1 Global Mycoplasma Detection System Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Mycoplasma Detection System Sales by Region: 2021-2032
- 5.2.1 Global Mycoplasma Detection System Sales by Region: 2021-2026
- 5.2.2 Global Mycoplasma Detection System Sales by Region: 2027-2032
- 5.3 Global Mycoplasma Detection System Revenue by Region: 2021-2032
- 5.3.1 Global Mycoplasma Detection System Revenue by Region: 2021-2026
- 5.3.2 Global Mycoplasma Detection System Revenue by Region: 2027-2032
- 5.4 North America Mycoplasma Detection System Market Facts & Figures by Country
- 5.4.1 North America Mycoplasma Detection System Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Mycoplasma Detection System Sales by Country (2021-2032)
- 5.4.3 North America Mycoplasma Detection System Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Mycoplasma Detection System Market Facts & Figures by Country
- 5.5.1 Europe Mycoplasma Detection System Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Mycoplasma Detection System Sales by Country (2021-2032)
- 5.5.3 Europe Mycoplasma Detection System Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Mycoplasma Detection System Market Facts & Figures by Country
- 5.6.1 Asia Pacific Mycoplasma Detection System Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Mycoplasma Detection System Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Mycoplasma Detection System Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Mycoplasma Detection System Market Facts & Figures by Country
- 5.7.1 South America Mycoplasma Detection System Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Mycoplasma Detection System Sales by Country (2021-2032)
- 5.7.3 South America Mycoplasma Detection System Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Mycoplasma Detection System Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Mycoplasma Detection System Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Mycoplasma Detection System Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Mycoplasma Detection System Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Mycoplasma Detection System Sales by Type (2021-2032)
- 6.1.1 Global Mycoplasma Detection System Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Mycoplasma Detection System Sales Market Share by Type (2021-2032)
- 6.2 Global Mycoplasma Detection System Revenue by Type (2021-2032)
- 6.2.1 Global Mycoplasma Detection System Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Mycoplasma Detection System Revenue Market Share by Type (2021-2032)
- 6.3 Global Mycoplasma Detection System Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Mycoplasma Detection System Sales by Application (2021-2032)
- 7.1.1 Global Mycoplasma Detection System Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Mycoplasma Detection System Sales Market Share by Application (2021-2032)
- 7.2 Global Mycoplasma Detection System Revenue by Application (2021-2032)
- 7.2.1 Global Mycoplasma Detection System Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Mycoplasma Detection System Revenue Market Share by Application (2021-2032)
- 7.3 Global Mycoplasma Detection System Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Mycoplasma Detection System Value Chain Analysis
- 8.1.1 Mycoplasma Detection System Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Mycoplasma Detection System Production Mode & Process
- 8.2 Mycoplasma Detection System Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Mycoplasma Detection System Distributors
- 8.2.3 Mycoplasma Detection System Customers
9 Global Mycoplasma Detection System Analyzing Market Dynamics
- 9.1 Mycoplasma Detection System Industry Trends
- 9.2 Mycoplasma Detection System Industry Drivers
- 9.3 Mycoplasma Detection System Industry Opportunities and Challenges
- 9.4 Mycoplasma Detection System Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst